Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype
about
A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.Staphylococcus aureus Colonization of the Mouse Gastrointestinal Tract Is Modulated by Wall Teichoic Acid, Capsule, and Surface ProteinsIdentification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responsesNovel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formationThe dissemination of C10 cysteine protease genes in Bacteroides fragilis by mobile genetic elementsThe effect of environmental conditions on expression of Bacteroides fragilis and Bacteroides thetaiotaomicron C10 protease genes.Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureusNsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus.The AirSR two-component system contributes to Staphylococcus aureus survival in human blood and transcriptionally regulates sspABC operonInactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureusRegulation of bacterial protease activity.Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.The ω Subunit Governs RNA Polymerase Stability and Transcriptional Specificity in Staphylococcus aureus.Characterization of the glutamyl endopeptidase from Staphylococcus aureus expressed in Escherichia coli.The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity.
P2860
Q24814657-579D416B-9074-45DA-B7DE-D53E3035AD35Q27318407-732048EC-7E33-401A-9A6B-9F31F75C4322Q28474120-31C79118-6FAF-4A48-86C3-DB5C283C274CQ28484413-101399AE-DAEF-4DE9-A376-9D708B217BBFQ33563189-1538AF3C-CD8A-4955-9B29-7562088A1CFFQ34401958-9B4571BC-DC40-49EA-A262-C371489DD232Q35075278-B498A4ED-88F3-40D9-ACF2-CAF96A9D4D7AQ35199089-86956546-F7D0-4120-9D48-63A931575C3AQ35812994-C0FC8E34-3856-4978-82EF-7446D5F3011EQ35947338-A4C168D6-12E6-4F91-955F-779717270090Q37008491-784B178A-20A8-4C05-BD3E-EA152EC474F8Q37190222-8DC5E043-F37F-471E-8E28-E28ECD9436A0Q37543439-14C5EE4D-C296-4F37-935A-1A77678396EFQ46805334-B6C6610D-877B-4D3F-9068-2BF7FBA79748Q54559491-7DABCD0F-7114-480E-808A-12F43D0D2D5B
P2860
Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@ast
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@en
type
label
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@ast
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@en
prefLabel
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@ast
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@en
P2093
P2860
P1476
Cytoplasmic control of prematu ...... profound pleiotropic phenotype
@en
P2093
Ewa Golonka
Grzegorz Szmyd
James Travis
Lindsey N Shaw
Simon J Foster
P2860
P304
P356
10.1128/JB.187.5.1751-1762.2005
P407
P50
P577
2005-03-01T00:00:00Z